Literature DB >> 34135456

From HDLS to BANDDOS: fast-expanding phenotypic spectrum of disorders caused by mutations in CSF1R.

Long Guo1, Shiro Ikegawa2.   

Abstract

Colony-stimulating factor 1 receptor (CSF1R) plays key roles in the development and function of the cells in the monocyte/macrophage lineage, including microglia and osteoclasts. It is well known that mono-allelic mutations of CSF1R cause hereditary diffuse leukoencephalopathy with spheroids (HDLS, OMIM # 221820), an adult-onset progressive neurodegenerative disorder. Recently, a more severe phenotypic spectrum has been identified in individuals with bi-allelic mutations of CSF1R. In addition to leukoencephalopathy of earlier onset than HDLS, the new disease shows brain malformations and skeletal dysplasia compatible with dysosteosclerosis (DOS), thus named "brain abnormalities, neurodegeneration, and dysosteosclerosis" (BANDDOS, OMIM # 618476). In addition, some individuals with bi-allelic missense mutations of CSF1R have been found to present with incomplete BANDDOS where skeletal dysplasia is absent. In this review, we summarize the monogenic disorders caused by mutations in CSF1R and their mutational spectra, and propose a dose-dependent model to explain the complex genotype-phenotype association.
© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34135456     DOI: 10.1038/s10038-021-00942-w

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

Review 1.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

2.  Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy.

Authors:  Jiwei Jiang; Wenyi Li; Xiaohong Wang; Zhongli Du; Jinlong Chen; Yaou Liu; Wei Li; Zhonghua Lu; Yanli Wang; Jun Xu
Journal:  Front Cell Dev Biol       Date:  2022-05-24

3.  Reply to: Adult-onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?

Authors:  Yi-Chung Lee; Yi-Chu Liao
Journal:  Ann Clin Transl Neurol       Date:  2022-01-04       Impact factor: 4.511

4.  Adult-onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?

Authors:  Ettore Salsano; Chiara Benzoni
Journal:  Ann Clin Transl Neurol       Date:  2022-01-04       Impact factor: 4.511

5.  Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity.

Authors:  Serap Turan; Steven Mumm; Ceren Alavanda; Betul Sare Kaygusuz; Busra Gurpinar Tosun; Ahmet Arman; Margaret Huskey; Tulay Guran; Shenghui Duan; Abdullah Bereket; Michael P Whyte
Journal:  JBMR Plus       Date:  2022-07-28

6.  A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling.

Authors:  Jennifer Stables; Emma K Green; Anuj Sehgal; Omkar L Patkar; Sahar Keshvari; Isis Taylor; Maisie E Ashcroft; Kathleen Grabert; Evi Wollscheid-Lengeling; Stefan Szymkowiak; Barry W McColl; Antony Adamson; Neil E Humphreys; Werner Mueller; Hana Starobova; Irina Vetter; Sepideh Kiani Shabestari; Matthew M Blurton-Jones; Kim M Summers; Katharine M Irvine; Clare Pridans; David A Hume
Journal:  Development       Date:  2022-03-25       Impact factor: 6.868

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.